Skip to content

Plandai Biotechnology, Inc.: 10-Q filed 2014-02-19

What Plandai Biotechnology, Inc. reported in its quarterly report filed 2014-02-19 (fiscal Q2 2014): 32 published measures, 81 facts as tagged in accession 0001262463-14-000150.

This filing

Form
10-Q (quarterly report)
Filed
2014-02-19
Fiscal period
fiscal Q2 2014
Accession
0001262463-14-000150 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Plandai Biotechnology, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-318,731,880USD
At 2013-06-308,835,482USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3114,429,892USD
At 2013-06-3012,319,844USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31-5,698,012USD
At 2013-06-30-3,484,362USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-31131,545USD
At 2013-06-30498,917USD
At 2012-12-311,385,912USD
At 2012-06-305,112USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-3,320,564USD92
2013-07-01 to 2013-12-31-4,044,655USD184
2012-10-01 to 2012-12-31-442,735USD92
2012-07-01 to 2012-12-31-927,062USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-07-01 to 2013-12-31-1,133,613USD184
2012-07-01 to 2012-12-31-747,891USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-07-01 to 2013-12-31387,267USD184
2012-07-01 to 2012-12-31885,285USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-10-01 to 2013-12-3113,187USD92
2013-07-01 to 2013-12-31240,002USD184
2012-10-01 to 2012-12-31113,816USD92
2012-07-01 to 2012-12-31249,903USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-07-01 to 2013-12-311,153,508USD184
2012-07-01 to 2012-12-313,429,794USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-07-01 to 2013-12-31-387,267USD184
2012-07-01 to 2012-12-31-1,301,103USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-14,592,562USD
At 2013-06-30-10,903,813USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-318,212,899USD
At 2013-06-307,924,910USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-1,314,305USD92
2013-07-01 to 2013-12-31-1,718,537USD184
2012-10-01 to 2012-12-31-409,159USD92
2012-07-01 to 2012-12-31-824,023USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-31142,321USD
At 2013-06-30518,994USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-10-01 to 2013-12-31147,860USD92
2013-07-01 to 2013-12-31239,682USD184
2012-10-01 to 2012-12-3133,576USD92
2012-07-01 to 2012-12-31105,692USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-312,678,926USD
At 2013-06-30903,740USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-317,007USD
At 2013-06-3013,638USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-10-01 to 2013-12-311,160,578USD92
2013-07-01 to 2013-12-311,614,684USD184
2012-10-01 to 2012-12-31522,975USD92
2012-07-01 to 2012-12-31698,797USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-313,769USD
At 2013-06-306,439USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-153,727USD92
2013-07-01 to 2013-12-31-103,853USD184
2012-10-01 to 2012-12-31113,816USD92
2012-07-01 to 2012-12-31-125,226USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-31111,070,760shares
At 2013-06-30106,270,760shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-318,755,999USD
At 2013-06-307,833,976USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2013-12-31-4,485,916USD
At 2013-06-30-2,628,172USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-318,421,830USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-31208,931USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-31361,138USD
At 2013-06-30380,929USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-3112,472USD
At 2013-06-3093,184USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-3,027,198USD92
2013-07-01 to 2013-12-31-3,575,248USD184
2012-10-01 to 2012-12-31-331,660USD92
2012-07-01 to 2012-12-31-690,412USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-3121,307USD92
2013-07-01 to 2013-12-31102,326USD184
2012-10-01 to 2012-12-31193,640USD92
2012-07-01 to 2012-12-31238,657USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-10-01 to 2013-12-3149,235USD92
2013-07-01 to 2013-12-3199,278USD184
2012-10-01 to 2012-12-3114,412USD92
2012-07-01 to 2012-12-3146,680USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-12-316,632USD184
2012-07-01 to 2012-12-31-12USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-12-312,670USD184

Inspect the source

Entity
Plandai Biotechnology, Inc. / CIK 0001317880
Captured
SEC response SHA-256
e24b67d85b1d2e03527e4a75cf3f495a155375a1a0e10302aff7f4632fcf21aa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001317880.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))